Activity

Filter

Cancel
Date Panel Item Activity
6 actions
BabyScreen+ newborn screening v0.1948 FAM111A Zornitza Stark Marked gene: FAM111A as ready
BabyScreen+ newborn screening v0.1948 FAM111A Zornitza Stark Gene: fam111a has been classified as Green List (High Evidence).
BabyScreen+ newborn screening v0.1948 FAM111A Zornitza Stark Classified gene: FAM111A as Green List (high evidence)
BabyScreen+ newborn screening v0.1948 FAM111A Zornitza Stark Gene: fam111a has been classified as Green List (High Evidence).
BabyScreen+ newborn screening v0.1947 FAM111A Zornitza Stark Tag treatable tag was added to gene: FAM111A.
Tag skeletal tag was added to gene: FAM111A.
BabyScreen+ newborn screening v0.1947 FAM111A Zornitza Stark gene: FAM111A was added
gene: FAM111A was added to Baby Screen+ newborn screening. Sources: Expert Review
Mode of inheritance for gene: FAM111A was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes for gene: FAM111A were set to Kenny-Caffey syndrome, type 2, MIM# 127000
Review for gene: FAM111A was set to GREEN
Added comment: Condition is characterised by impaired skeletal development with small and dense bones, short stature, ocular abnormalities, and primary hypoparathyroidism with hypocalcemia. At least 10 unrelated cases reported with de novo missense variants. Intellectual disability/developmental delay is a rare feature of the condition.

Treatment: magnesium, calcium and calcitriol or alfacalcidol

Non-genetic confirmatory testing: serum calcium, parathyroid hormone level, calcitonin level
Sources: Expert Review